Introduction {#s01}
============

Peroxisomes house diverse metabolic functions, notably those involved in lipid metabolism and reactive oxygen detoxification ([@bib4]; [@bib35]; [@bib41]). In humans, defects in peroxisome biogenesis cause neurological diseases, such as Zellweger syndrome ([@bib6]; [@bib13]; [@bib43]). While peroxisome membrane proteins are probably derived from the ER, matrix proteins are synthesized in the cytosol and must then be transported across the peroxisome membrane ([@bib19]; [@bib1]). Most matrix proteins use a C-terminal Ser-Lys-Leu (SKL) sequence as an import signal, otherwise known as the peroxisome targeting signal 1 (PTS1; [@bib17]). This motif is recognized by the import receptor Pex5 through its C-terminal tetratricopeptide repeat domain ([@bib22]; [@bib38]; [@bib7]). Pex5 uses an N-terminal domain to bind to a docking complex on the peroxisome membrane, which contains Pex13 and Pex14 as conserved subunits ([@bib12]; [@bib18]; [@bib2]). The PTS1 cargo is then translocated across the peroxisome membrane by mechanisms that have not been fully elucidated. The current evidence also suggests that Pex5 is mono-ubiquitinated at a conserved Cys residue close to its N terminus ([@bib9]; [@bib46]). Pex5 is subsequently returned to the cytosol by an ATPase complex and can start a new translocation cycle ([@bib29]). Despite progress over several decades, important aspects of peroxisome import remain unclear. A particularly mysterious point is the reported import of folded proteins and oligomeric assemblies ([@bib21]).

Further progress on the mechanism of peroxisome protein import critically depends on in vitro experiments in which components can be depleted and manipulated. Several in vitro import assays have been reported, either based on permeabilized cells or fractionated extracts ([@bib14]; [@bib44]; [@bib32]; [@bib27]). However, none of these systems has been used extensively, probably because they have to be prepared freshly, or are difficult to reproduce, or import is of low efficiency and hard to quantify. A confounding problem with in vitro systems is the fragility of peroxisomes, which makes the use of purified organelles difficult. Here, we describe a reliable and quantifiable in vitro system based on *Xenopus laevis* egg extracts, which recapitulates peroxisome protein import. We use this assay to investigate several aspects of the mechanism of peroxisome protein import.

Results {#s02}
=======

An in vitro system for peroxisome protein import {#s03}
------------------------------------------------

*Xenopus* egg extracts have been used extensively to reproduce various biological processes, as they contain all cellular components at physiological concentrations. We therefore decided to test this system for peroxisome protein import. Eggs from the frog *X. laevis* were centrifuged in the absence of the Ca^2+^-chelator EGTA to move the extract into interphase of the cell cycle ([@bib42]). The resulting crude extract was subjected to ultra-centrifugation in the absence of the actin-depolymerizing reagent cytochalasin D. The gel-like cytosolic fraction and membranes contained in it were collected and frozen in aliquots (Fig. S1 A). Glycogen and a large portion of the membranes sedimented to the bottom of the tube and were discarded. The isolated membrane/cytosol material, called "cleared *Xenopus* extract," is active in peroxisome protein transport after thawing (see below). The extract contains peroxisomes (see below), as well as ER and mitochondria (Fig. S1 B), and it maintains microtubule and ER dynamics even after thawing (Fig. S1 C). Extracts generated with the normal procedure, which involves the addition of cytochalasin D before sedimentation of the membranes, also showed peroxisome protein import, but they lost activity for import and microtubule dynamics after freeze-thawing (data not shown). The generation of cleared *Xenopus* extract may provide a facile alternative to a recently reported procedure to generate frozen extracts for the study of other biological processes ([@bib37]).

To test for peroxisome protein transport, we fused a C-terminal SKL sequence to a fluorescent protein, either superfolder GFP, mCherry, or mScarlet. These proteins were expressed in *Escherichia coli* and purified using N-terminal His tags, followed by gel filtration (Fig. S2). After incubation of the purified fusion proteins with cleared *Xenopus* extract, bright foci were observed (shown for mCherry in [Fig. 1 A](#fig1){ref-type="fig"}). In contrast, no foci were seen with fluorescent proteins lacking the SKL sequence ([Fig. 1 B](#fig1){ref-type="fig"}). Foci formation was prevented when the incubation of mCherry-SKL was performed in the presence of an excess of a synthetic peptide that contains the SKL sequence at its C terminus ([Fig. 1 C](#fig1){ref-type="fig"}). In contrast, foci formation was not perturbed by a control peptide that contains the sequence KLS at its C terminus ([Fig. 1 D](#fig1){ref-type="fig"}), a sequence that does not function as a PTS1 signal ([@bib24]). These results suggest that the foci correspond to peroxisomes that bound or imported proteins containing a PTS1 signal. It should be noted that the extract was not fixed, allowing the foci to move freely (Video 1).

![**Peroxisome targeting of SKL-containing fluorescent proteins in *Xenopus* egg extracts. (A)** Cleared egg extract was incubated with 0.9 µM purified mCherry-SKL for 1 h at 18°C. The formation of bright puncta was visualized with a spinning-disk confocal microscope. **(B)** As in A, but with mCherry lacking the SKL targeting sequence. **(C)** As in A, but in the presence of a synthetic peptide (300 µM) with a C-terminal SKL sequence. **(D)** As in C, but with a peptide containing a scrambled import signal at its C terminus (KLS). **(E)** Cleared egg extract was incubated with 0.6 µM purified mScarlet-SKL for 5 h at 18°C. The sample was subjected to flotation in a discontinuous sucrose gradient. Fractions were collected and analyzed with a fluorescence microscope. Shown is the bottom fraction containing nonimported substrate. **(F)** As in E, but for the top fraction, containing peroxisome-associated substrate. **(G)** Quantification of the number of fluorescent peroxisome foci in the different fractions of the sucrose gradient. Shown are the mean and standard deviation from \>40 images of two different experiments. **(H)** All fractions of the sucrose gradient were analyzed by SDS-PAGE, followed by immunoblotting with antibodies against the peroxisome membrane protein Pex14. Bars, 5 µm.](JCB_201901152_Fig1){#fig1}

To test whether the fluorescent puncta correspond to peroxisomes, we performed an import reaction with mScarlet-SKL and then subjected the mixture to flotation in a discontinuous sucrose gradient. Fractions were analyzed by fluorescence imaging (bottom and top fractions are shown in [Fig. 1, E and F](#fig1){ref-type="fig"}, respectively) and the number of foci was quantified using an automated script ([Fig. 1 G](#fig1){ref-type="fig"}). Essentially all fluorescent foci floated to the top of the gradient. Immunoblotting with an antibody raised against a N-terminal domain of the peroxisomal membrane protein Pex14 showed that these fractions also contained endogenous peroxisomes ([Fig. 1 H](#fig1){ref-type="fig"}). Non-imported mScarlet-SKL substrate stayed at the bottom of the gradient and showed diffuse fluorescence ([Fig. 1 E](#fig1){ref-type="fig"}). These results provide evidence that the foci correspond to peroxisomes and are not caused by protein aggregation.

To distinguish between substrate binding to peroxisomes and actual import into these organelles, we followed the accumulation of mScarlet-SKL at peroxisomes over time. Given that substrate was added in excess over endogenous Pex5 and docking protein complex ([@bib47]), we reasoned that the fluorescence of each peroxisome would plateau rapidly if the substrate was only binding, whereas it would increase linearly if the substrate was imported. To follow substrate over time, we placed the reaction mix into a small microscope chamber and imaged it repeatedly. An automated script was developed to identify peroxisomes in the images and calculate their average fluorescence. At early time points, the detection of peroxisomes was difficult because of their weak fluorescence, but imaging at later time points showed that their average fluorescence increased linearly over several hours ([Fig. 2 A](#fig2){ref-type="fig"}). These data are consistent with real protein import into peroxisomes. The addition of the nonhydrolysable ATP analogue ATPγS drastically reduced import, although import was still detectable at the beginning of the reaction ([Fig. 2 A](#fig2){ref-type="fig"}), perhaps because a single round of peroxisome protein import can occur in the absence of ATP hydrolysis. Depletion of ATP from crude extracts by blocking ATP production by both mitochondrial respiration and glycolysis also inhibited peroxisome protein import (Fig. S3).

![**Peroxisome protein import in *Xenopus* egg extract. (A)** mScarlet-SKL (0.6 µM) was added at time point zero to cleared *Xenopus* egg extract. Where indicated, 5 or 10 mM ATPγS was added 20 min before substrate. The samples were immediately mounted on PEG-passivated glass coverslips and imaged at the indicated time points, using a spinning-disk confocal microscope. The mean fluorescence of peroxisomes was determined from \>10 images using an automated image analysis script. Shown are the combined data of two different experiments (\>20 images per time point), each normalized to the final time point of the control. For each time point, the mean and the standard deviation of the mean are given. **(B)** Cleared extract was incubated with 0.5 µM GFP-SKL for 1 h at 20--23°C and imaged with a spinning-disk confocal microscope. **(C)** As in B but at the end of the incubation, 0.75 µM GFP-fluorescence quenching nanobodies ([@bib20]) were added for ∼15 min before imaging. **(D)** Quantification of the mean peroxisome fluorescence in B and C of two separate import reactions. Shown are the mean and standard deviation of \>20 images. **(E)** As in B, but with GFP lacking the SKL sequence. **(F)** As in C, but with GFP lacking the SKL sequence. **(G)** Quantification of the total fluorescence in E and F of two separate import reactions. Shown are the mean and standard deviation of \>20 images. **(H)** mScarlet-SKL (0.6 µM) was incubated with cleared egg extract for 1 h at 18°C. The membranes were sedimented twice by centrifugation and resuspension in buffer. The sample was imaged directly in a confocal microscope. **(I)** As in H, but the sample was subjected to three freeze--thaw cycles before imaging. **(J)** GFP-SKL (0.4 µM) was incubated with crude extract for 1 h and imaged. **(K)** As in J, but 0.1% Triton X-100 was added before imaging. Bars, 10 µM.](JCB_201901152_Fig2){#fig2}

To directly test for substrate translocation, we used GFP-quenching nanobodies ([@bib20]) and asked whether the peroxisome membrane would prevent quenching of previously imported GFP-SKL. When the nanobodies were added after incubation of the extract with GFP-SKL, the foci remained unquenched, whereas residual, nonimported substrate was quenched, as seen by a decrease of the background fluorescence ([Fig. 2 C](#fig2){ref-type="fig"} versus [Fig. 2 B](#fig2){ref-type="fig"}). Quantification confirmed that the fluorescence of the peroxisomes was unaffected by the quenching nanobodies, whereas the unimported material was quenched ([Fig. 2 D](#fig2){ref-type="fig"}). These data suggest that the substrate is inside the peroxisomes and therefore inaccessible to the nanobodies. No foci were seen with GFP lacking SKL, and ∼80% of the total fluorescence was quenched by the nanobodies ([Fig. 2, E--G](#fig2){ref-type="fig"}).

Additional support for real substrate import comes from experiments in which we isolated peroxisomes after import of mScarlet-SKL. More than 80% of the fluorescent foci could be recovered after two rounds of sedimentation and resuspension. However, when the resuspended sample was subjected to three freeze--thaw cycles, all foci were lost, as expected from such treatment disrupting the peroxisome membrane ([Fig. 2 H](#fig2){ref-type="fig"}). Addition of detergent had the same effect ([Fig. 2 I](#fig2){ref-type="fig"}). Taken together, these experiments provide strong evidence that the *Xenopus* system recapitulates actual protein import into peroxisomes.

Peroxisome protein import depends on Pex5 and its membrane receptor Pex14 {#s04}
-------------------------------------------------------------------------

Next, we tested whether peroxisome foci formation depends on the known import components Pex5 and Pex14. To this end, we purified a Pex5-interacting cytosolic domain of the docking protein Pex14 (amino acids 17--78 in *Xenopus* Pex14; [@bib25]). The protein was expressed in *E. coli* as a glutathione S-transferase (GST) fusion, and purified after proteolytic removal of the GST tag (Fig. S2). Addition of this cytosolic Pex14 fragment to cleared *Xenopus* extract completely inhibited foci formation by GFP-SKL ([Fig. 3 A](#fig3){ref-type="fig"}; parallel control shown in [Fig. 3 B](#fig3){ref-type="fig"}) or mCherry-SKL (data not shown). Next, we coupled the cytosolic Pex14 fragment to a resin and used these beads to deplete the cleared extract of Pex5. The mock-depleted extract contained two major bands detected by immunoblotting with an antibody raised against *Xenopus* Pex5 ([Fig. 3 C](#fig3){ref-type="fig"}, lane 1), possibly corresponding to the short and long isoforms of Pex5 reported in other species ([@bib5]; [@bib28]). The intensity of both bands was reduced by ∼80% after incubation with Pex14 fragment--containing resin ([Fig. 3 C](#fig3){ref-type="fig"}, lane 2). The depleted extract was almost completely inactive in foci formation with GFP-SKL ([Fig. 3 D](#fig3){ref-type="fig"}; control with a mock-depleted extract shown in [Fig. 3 E](#fig3){ref-type="fig"}). To test whether Pex5 is the only essential component missing in the depleted extract, we performed rescue experiments. Full-length *Xenopus* Pex5, corresponding to the long isoform of Pex5 in other species, was expressed in *E. coli* as a GST fusion and purified after removal of the GST tag by gel filtration (Fig. S2). This protein migrated at the same position as the higher molecular weight band detected by immunoblotting in *Xenopus* extracts ([Fig. 3 C](#fig3){ref-type="fig"}, lane 3 versus lane 1). Addition of the recombinant Pex5 protein restored foci formation in a depleted extract ([Fig. 3 F](#fig3){ref-type="fig"}). As a control, we purified a Pex5 mutant in which a conserved Ala (Ala510) in the SKL-binding pocket of the tetratricopeptide repeat domain ([@bib15]) was mutated to Trp. Gel filtration experiments confirmed that the Pex5 Ala510Trp mutant bound mScarlet-SKL significantly more weakly than WT Pex5 (Fig. S4). Pex5 Ala510Trp did not restore foci formation in the depleted extract ([Fig. 3 G](#fig3){ref-type="fig"}). Taken together, these experiments suggest that our system reproduces Pex5- and Pex14-dependent peroxisome protein import.

![**Protein targeting to peroxisomes depends on Pex5 and Pex14. (A)** Cleared *Xenopus* egg extract was incubated for 1 h at 18°C with 0.5 µM GFP-SKL in the presence of 6 µM of a cytosolic fragment of the peroxisome docking protein Pex14 (cytPex14). The sample was imaged with a spinning-disk confocal microscope. **(B)** As in A, but without adding cytPex14. **(C)** Egg extract was incubated with beads containing immobilized cytPex14 and subjected to SDS-PAGE, followed by immunoblotting with Pex5 antibodies (lane 2). A control was done with beads lacking cytPex14 (lane 1; mock depletion). Purified, recombinant Pex5 was analyzed either without added extract (lane 3) or after addition of different amounts to depleted extract (lanes 4--6). MW, molecular weight. **(D)** Pex5-depleted extract was incubated for 1 h at 18°C with 0.5 µM GFP-SKL and imaged with a spinning-disk confocal microscope. **(E)** As in D, but with mock-depleted extract. **(F)** As in D, but in the presence of 1 µM purified Pex5. **(G)** As in F, but with 1 µM purified Pex5^A510W^, a Pex5 mutant defective in SKL binding. All experiments were performed at least three times. Bars, 10 µm.](JCB_201901152_Fig3){#fig3}

To further test this conclusion, we used cleared *Xenopus* extracts that were depleted of Pex5 with antibodies. Pex5 antibodies were isolated from crude antiserum with beads containing recombinant Pex5. After elution from the beads, the antibodies were coupled to a resin and then used to deplete cleared extract. Pex5 depletion was almost complete ([Fig. 4 A](#fig4){ref-type="fig"}). The depleted extract was entirely inactive ([Fig. 4 B](#fig4){ref-type="fig"} versus [Fig. 4 C](#fig4){ref-type="fig"}), but activity could be restored by addition of recombinant Pex5 ([Fig. 4 D](#fig4){ref-type="fig"}). When the Pex5-interacting cytosolic Pex14 fragment was also added, no foci were observed ([Fig. 4 E](#fig4){ref-type="fig"}). As before, addition of the SKL-binding mutant Ala510Trp did not restore foci formation ([Fig. 4 F](#fig4){ref-type="fig"}). These results further indicate that our *Xenopus* system recapitulates Pex5-dependent protein import into peroxisomes.

![**Peroxisome targeting in Pex5-depleted and -replenished egg extract. (A)** Cleared *Xenopus* egg extract was incubated with beads containing immobilized, affinity-purified antibodies to Pex5. The depleted extract was subjected to SDS-PAGE, followed by immunoblotting with Pex5 antibodies (lane 2). A control was done with beads lacking Pex5 antibodies (lane 1; mock depletion). In lane 3, 30 nM purified, recombinant Pex5 was added to the depleted extract. **(B)** Pex5-depleted extract was incubated with 0.6 µM mScarlet-SKL for 1 h at 18°C and imaged with a spinning-disk confocal microscope. **(C)** As in B, but with mock-depleted extract. **(D)** As in B, but in the presence of 0.5 µM purified Pex5. **(E)** As in D, but with additionally added 6 µM cytPex14. **(F)** As in D, but with 0.5 µM purified Pex5^A510W^, a Pex5 mutant defective in SKL binding. These experiments were performed twice. Bars, 10 µm.](JCB_201901152_Fig4){#fig4}

Next we tested the binding of Pex5 to peroxisomes. An 11-residue ybbR tag ([@bib48]) was added at the C terminus of Pex5, and the purified protein (Fig. S2) was labeled with Alexa Fluor 488. Labeled Pex5 was then added to the cleared *Xenopus* extract and its binding to peroxisomes followed over time in a fluorescent microscope ([Fig. 5 A](#fig5){ref-type="fig"}). Pex5 binding reached a plateau after 20 min, whereas substrate import in the same experiment continued for several hours ([Fig. 5 A](#fig5){ref-type="fig"}). Because of the mobility of the peroxisomes, the puncta recorded in the two fluorescent channels do not show exact colocalization, and the fluorescence ratio varies, but the pattern is similar enough to conclude that they correspond to the same puncta ([Fig. 5 B](#fig5){ref-type="fig"}). These experiments are consistent with the idea that Pex5 rapidly reaches a steady state of binding to and releasing from peroxisomes, while the substrate continuously accumulates inside the organelle.

![**Kinetics of Pex5 binding and peroxisome protein import. (A)** mScarlet-SKL (0.6 µM) and fluorescently labeled Pex5 (Pex5^Alexa488^; 0.15 µM) were added at time point zero to cleared *Xenopus* egg extract. The sample was mounted on a PEG-passivated glass chamber and imaged over time using a spinning-disk confocal microscope. The red (mScarlet-SKL) and green (Pex5^Alexa-488^) emission channels were imaged simultaneously. Shown are the combined data of two different experiments (\>20 images per time point), each normalized to the final time point of the control. For each time point, the mean and the standard deviation of the mean are given. **(B)** Images taken at 140 min sequentially in the two channels. The foci partially overlap (compare foci inside the oval). Overlap is not perfect because the peroxisomes are moving. Bars, 10 µm.](JCB_201901152_Fig5){#fig5}

Testing the role of the conserved Cys residue of Pex5 {#s05}
-----------------------------------------------------

In all species, Pex5 has a conserved Cys residue close to its N terminus (Cys11 in *Xenopus* Pex5), which seems to be mono-ubiquitinated, a modification that is thought to be required for the recycling of Pex5 from the peroxisome membrane back into the cytosol ([@bib4]; [@bib35]; [@bib41]). We used our depletion/add-back *Xenopus* system to test various Cys mutants. The Cys11Lys mutant was almost as active as the WT Pex5 protein in restoring peroxisome import in Pex5 antibody-depleted extracts ([Fig. 6 E](#fig6){ref-type="fig"} versus [Fig. 6 C](#fig6){ref-type="fig"}; controls in [Fig. 6, A and B](#fig6){ref-type="fig"}; and quantification in [Fig. 6 I](#fig6){ref-type="fig"}). Replacement of Cys11 with either Ala or Arg drastically reduced the activity of Pex5, but did not completely abolish it ([Fig. 6, F and G](#fig6){ref-type="fig"}). These mutants retained 10--20% of WT activity ([Fig. 6 I](#fig6){ref-type="fig"}), in contrast to the SKL-binding mutant A510W, which was completely inactive. These results are consistent with the idea that modification of Cys11 is only required for the recycling of Pex5, not for a single round of protein import. The Cys11Ser mutant did not support import (data not shown), but the protein may not have been correctly folded, as it was expressed in *E. coli* at lower levels than WT Pex5 or all other mutants and was prone to aggregation and proteolysis during purification.

![**Peroxisome protein import with Cys11 mutations in Pex5. (A)** *Xenopu*s cleared egg extract was mock-depleted with beads, as in [Fig. 3](#fig3){ref-type="fig"}, and incubated with 0.6 µM mScarlet-SKL for 1 h at 20--23°C. The sample was imaged with a spinning-disk confocal microscope. **(B)** As in A, but with an extract depleted of Pex5 with beads containing affinity-purified Pex5 antibodies (see [Fig. 3](#fig3){ref-type="fig"}). **(C)** As in B, but with 1 µM WT Pex5 added. **(D)** As in B, but with 1 µM Pex5^A510W^, defective in SKL binding. **(E)** As in B, but with 1 µM Pex5^C11A^. **(F)** As in B, but with 1 µM Pex5^C11R^. **(G)** As in B, but with 1 µM Pex5^C11K^. **(H)** Quantification of the end-point fluorescence in peroxisomes, using automated image analysis. Shown are the combined data of two parallel experiments (\>20 images). The mean and standard deviation of the mean are given. **(I)** WT Pex5 or the indicated Cys11 mutants were added at 1 µM to cleared, un-depleted extract. The samples were imaged at the indicated time points with a spinning-disk confocal microscope, and the mean fluorescence per peroxisome was determined by automated image analysis. Shown are the combined data of two experiments done on different days (\>20 images per time point), each normalized to the final time point of the brightest sample. For each time point, the mean and the standard deviation of the mean are given. Bars, 10 µm.](JCB_201901152_Fig6){#fig6}

To test whether the Pex5 mutants are dominant-negative, we added them to nondepleted cleared extracts and followed peroxisome import of mScarlet-SKL over time ([Fig. 6 J](#fig6){ref-type="fig"}). Although WT Pex5 and the Cys11Lys mutant had the greatest effect, even the Cys11Ala and Cys11Arg mutants stimulated import. Thus, these mutants are not dominant-negative, suggesting that any modification at Cys11 is not necessary to clear import sites for subsequent rounds of translocation.

Import of a folded protein into peroxisomes {#s06}
-------------------------------------------

Next we used the established in vitro system to test whether a folded protein can be imported into peroxisomes. We added mCherry-SKL to an interacting, fluorescently labeled nanobody (Alexa Fluor 488 nanobody) that lacks a SKL sequence, and then incubated the mixture with cleared *Xenopus* extract. Peroxisomes could be detected both by mCherry and Alexa Fluor 488 fluorescence ([Fig. 7, A and B](#fig7){ref-type="fig"}), indicating colocalization of the two interacting proteins. Import of the nanobody into peroxisomes was tested by adding after the import reaction IgG from monoclonal antibodies that quench Alexa Fluor 488 fluorescence ([@bib3]). Addition of IgG had no effect on the fluorescence of peroxisomes labeled with GFP or Alexa Fluor 488 ([Fig. 7, C and D](#fig7){ref-type="fig"}; quantification shown in [Fig. 7 E](#fig7){ref-type="fig"}). However, nonimported Alexa Fluor 488 nanobody was quenched, as seen by the reduction of background fluorescence ([Fig. 7 D](#fig7){ref-type="fig"}). As expected, no labeled peroxisomes were visible in either the mCherry or the Alexa Fluor 488 channel when mCherry lacked the SKL sequence ([Fig. 7, F--I](#fig7){ref-type="fig"}; quantification shown in [Fig. 7 J](#fig7){ref-type="fig"}). The addition of IgG reduced the total fluorescence only in the Alexa Fluor 488 channel ([Fig. 7 I](#fig7){ref-type="fig"}). Consistent with the coimport of mCherry-SKL and Alexa Fluor 488 nanobody into peroxisomes, the average fluorescence of peroxisomes increased with the same kinetics in both channels ([Fig. 7 K](#fig7){ref-type="fig"}). Taken together, these results indicate that the nanobody lacking an SKL sequence can be transported "piggyback" together with mCherry-SKL into peroxisomes. We also performed the reverse experiment with crude *Xenopus* extract: GFP lacking an SKL sequence could be imported into peroxisomes with a nanobody containing a C-terminal SKL sequence (Fig. S5). Given that the nanobody can only bind to folded fluorescent proteins, the complex is likely transported without prior dissociation.

![**Transport of a folded protein into peroxisomes. (A)** mCherry-SKL (40 µM) was preincubated with mCherry-nanobodies labeled with Alexa Fluor 488 (nanobody^Alexa488^; 40 µM) for 20 min at 20--23°C. The complex was added at 0.9 µM final concentration to cleared *Xenopus* egg extract. The sample was incubated for 2 h at 18°C and imaged with a spinning-disk confocal microscope for mCherry fluorescence. **(B)** The same field shown in A was imaged for nanobody^Alexa488^ fluorescence. The foci in A and B overlap (compare foci in ovals). **(C)** As in A, but Alexa Fluor 488-fluorescence--quenching antibodies (0.5 µM) were added after the import reaction. **(D)** The same field as in C was analyzed for Alexa Fluor 488 fluorescence. The foci in C and D overlap (compare foci in ovals). **(E)** Quantification of the experiments in A--D. Shown are the combined data of two parallel experiments in the absence or presence of the quenching antibodies (\>20 images per condition). The fluorescence in each channel observed in the presence of quencher was normalized relative to the mean fluorescence in the absence of quencher. The mean and standard deviation of the mean are given. **(F)** As in A, but with mCherry lacking SKL. **(G)** The same field shown in F was imaged for nanobody^Alexa488^ fluorescence. **(H)** As in F, but Alexa Fluor 488-fluorescence--quenching antibodies (0.5 µM) were added after the import reaction. **(I)** The same field as in H was analyzed for Alexa Fluor 488 fluorescence. **(J)** Quantification of the experiments in F--I. Shown are the combined data of two parallel experiments in the absence or presence of the quenching antibodies (\>20 images per condition). The fluorescence in each channel observed in the presence of quencher was normalized relative to the mean fluorescence in the absence of quencher. The mean and standard deviation of the mean are given. **(K)** Kinetics of the accumulation of mCherry-SKL and nanobody^Alexa488^ in peroxisomes. The fluorescence in both channels was quantitated at the indicated time points by automated image analysis. Shown are the mean and standard deviation of the combined data of two parallel experiments (\>20 images per time point). Bars, 5 µm.](JCB_201901152_Fig7){#fig7}

Discussion {#s07}
==========

We have developed a new in vitro assay based on *Xenopus* egg extracts that recapitulates peroxisome protein import. In this system, fluorescent proteins that carry a SKL sequence at their C terminus are imported into peroxisomes in a process that is dependent on the import receptor Pex5 and its docking complex component Pex14. Sustained import is dependent on ATP hydrolysis and can occur with folded proteins.

Our in vitro system has several advantages over others reported before: import can be followed over time without fixation and is quantifiable, highly reproducible, and easily performed, as the extract can be frozen and thawed. Our "cleared extract" retains not only peroxisome protein import but also other activities seen with crude *Xenopus* extracts. The protocol for extract preparation is much simpler than a method recently reported for the study of spindle mechanics ([@bib37]), and it might generally replace crude extracts, which cannot be subjected to a freeze--thaw cycle and therefore suffer from reproducibility.

Multiple pieces of evidence suggest that the system recapitulates actual protein import into peroxisomes, rather than mere binding to the surface. First, imported fluorescent substrate is inaccessible to quenching nanobodies or antibodies. Second, the substrate accumulates linearly over an extended time period, while Pex5 binding rapidly reaches a plateau. Third, substrate is released after freeze--thaw cycles or detergent addition. However, we found that only a small percentage of imported substrate is protected when reisolated peroxisomes are treated with protease (data not shown). One possibility is that the peroxisome membrane becomes fragile during proteolysis, but perhaps some portion of the imported substrate remained exposed to the cytosol.

We provide strong evidence that a folded protein lacking a SKL sequence can be piggyback imported into peroxisomes. Previous experiments also reached the conclusion that folded or oligomeric proteins can be imported ([@bib8]; [@bib39], [@bib40]), but caveats can be raised for each reported study. In several cases, it could not be excluded that proteins are first unfolded and then refolded inside peroxisomes. In other cases, import of folded proteins was not unambiguously demonstrated or its efficiency was not established. For example, microinjection of gold nanoparticles conjugated to a peroxisome targeting signal showed their import into peroxisomes, but many particles could be detected outside the peroxisomes, and the extent of enrichment in peroxisomes remained unclear ([@bib40]). Most experiments assessed peroxisome localization by differential centrifugation, in which peroxisome content tends to distribute across many fractions. Perhaps the best data in the field come from in vivo piggyback experiments ([@bib16]; [@bib23]; [@bib11]), but it remained unclear how much of the substrate was really imported, rather than only associated with peroxisomes. In contrast, our experiments show that a prefolded SKL-containing fluorescent protein accumulates with the same kinetics as the associated nanobody in peroxisomes, and that the piggyback imported nanobody is completely shielded from quenching antibodies. In principle, it is conceivable that the protein complex dissociates after binding to peroxisomes and that actual membrane translocation of the two binding partners occurs sequentially, but their identical import kinetics would be difficult to explain, as the SKL-containing protein has an affinity for the docking complex, whereas the dissociated binding partner would be expected to frequently move back into the cytosol.

The mechanism by which folded proteins move across the peroxisome membrane remains unclear. However, in the only other known system in which folded proteins cross a membrane, the Tat secretion system in bacteria, two components distort the bilayer: the single-spanning TatA component appears to thin the bilayer through its short trans-membrane segment ([@bib33]), and the multi-spanning TatC protein has a deep cytosolic hydrophilic cavity ([@bib34]; [@bib31]). Perhaps translocation across the peroxisome membrane also occurs through a protein-distorted lipid bilayer.

Our Pex5 depletion and rescue experiments show that the conserved Cys residue at the N terminus of Pex5 (Cys11 in mammals) can be replaced by a Lys residue, just as in experiments in yeast ([@bib30]; [@bib46]). According to the prevailing model of import, Pex5 would be ubiquitinated at the Cys or Lys and then be returned into the cytosol by the Pex1/Pex6 ATPase to start a new targeting cycle ([@bib9]; [@bib30]; [@bib46]; [@bib26]). Indeed, in our experiments, ATPγS inhibited import with some delay, as would be expected if the recycling of Pex5 was affected. Our results show that replacement of the Cys residue by Ala or Arg does not completely abolish import, which again would be consistent with this model if one assumes that these mutants can only perform one round of import. Surprisingly, however, the Ala and Arg mutants stimulate import when added to an extract that has not been depleted of Pex5, rather than being dominant-negative ([Fig. 6 I](#fig6){ref-type="fig"}). These results suggest that modification of the Cys residue of Pex5 is not absolutely required to clear the import sites on peroxisomes for the next round of translocation. The reported dominant-negative effect of the Cys11Ala mutant in mammalian tissue culture cells might be caused by its extended expression for 48 h ([@bib26]).

In summary, this novel in vitro assay recapitulates peroxisome protein import, provides mechanistic insight, and will be useful for further dissecting the molecular mechanism of the process.

Materials and methods {#s08}
=====================

Plasmids {#s09}
--------

*Xenopus tropicalis* Pex5 cDNA coding for the long isoform (GenBank accession no. [BC088562](BC088562).1) was purchased from GE Healthcare. The open reading frame of Pex5 was amplified by PCR and cloned into the expression vector pGEX-6p-3 (GE Healthcare) immediately downstream of the 3C protease cleavage site using the Gibson Assembly (NEB). The open reading frame of *Xenopus* Pex14 was synthesized (Genscript) based on a Pex14 protein sequence obtained from mass spectrometry data ([@bib47]). The N-terminal, Pex5-interacting domain of *X. laevis* Pex14 was predicted based on the homology to human Pex14 (PDB code [2W84](2W84)). Pex14 residues 19 to 78 (cytPex14) were cloned into the expression vector pGEX-6p-3, as described for Pex5. Anti-GFP minimizer nanobody and anti-mCherry nanobody plasmids were purchased from Addgene (61838 and 70696, respectively). The open reading frames of the nanobodies were cloned into the vector pGEX-6p-3, as described for Pex5. Except for GFP, SKL-tagged and control fluorescent proteins constructs were made as described for Pex5, but SKL-tagged constructs contained the DNA sequence 5′-TCTAAACTG-3′ before the stop codon. GFP-SKL was purified via an N-terminal His tag on a Ni-NTA resin. cytATL (residues 1--462 of *X. laevis* atlastin) was synthetized by Genscript and cloned as described for Pex5. A ybbR-tagged Pex5 construct (Pex5-ybbR; [@bib48]) was created by inserting the tag sequence at the 3′-end of a C-terminally extended isoform of *X. tropicalis* Pex5 (X1 Pex5; NCBI accession no. [XP_012821977](XP_012821977).1), using PCR of the vector followed by DNA phosphorylation and plasmid recircularization by ligation. Point mutations in the respective constructs were generated using the QuickChange Site-Directed Mutagenesis kit (Agilent Technologies). All plasmid inserts were confirmed by DNA sequencing.

Protein expression and purification {#s10}
-----------------------------------

All recombinant proteins were expressed in BL21 (DE3) Rosetta (Novagen) *E. coli* strains (EMD Millipore). Bacterial cultures were grown at 37°C until OD~600nm~ reached 0.5. Then 0.5 mM isopropyl β-D-1-thiogalactopyranoside was added to the culture, the temperature was reduced to 18°C, and incubation was continued for an additional 16 h. Harvested bacteria were lysed using a microfluidizer. GST-tagged protein was isolated using glutathione Sepharose 4B resin (GE Healthcare). The GST tag was removed by on-column digestion with GST-tagged 3C protease (BPS Bioscience) overnight at 4°C. The protein was further purified by gel filtration (Superdex 200; GE Healthcare). The samples were concentrated and subjected to centrifugation at 20,000 × g for 10 min at 4°C before snap-freezing in liquid nitrogen using 0.2-ml PCR tubes. The final storage buffer for all proteins was 20 mM Hepes, pH 7.8, 150 mM KCl, 250 mM sucrose, and 1 mM DTT.

Peptides {#s11}
--------

A nine-residue peptide corresponding to the C-terminal sequence of the peroxisome matrix protein malate dehydrogenase 3 from *Saccharomyces cerevisiae* (N-EFILDSSKL-C) was synthesized by Genscript. A control peptide was synthesized in which the C-terminal SKL sequence was changed to KLS. These peptides contained acetylated N termini and unmodified C termini. The lyophilized peptides were resuspended at 10 mM in 100 mM Hepes, pH 7.8, and 100 mM KCl.

Fluorescent labeling of proteins {#s12}
--------------------------------

The anti-mCherry nanobody was labeled at Lys residues using N-hydroxysuccinimide-ester Alexa Fluor 488 (Thermo Fisher Scientific) as follows. 120 µM nanobody was incubated with 240 µM of the dye in reaction buffer (50 mM Hepes, pH 7.8, and 100 mM KCl) for 2 h at 23°C with gentle agitation. The reaction was stopped by addition of 100 mM Tris buffer, pH 7.8, and unreacted dye was removed by gel filtration on a Superdex 200 10/30 column (GE Healthcare), using 30 mM Hepes, pH 7.8, and 150 mM KCl as a running buffer. The efficiency of the labeling reaction was determined to be 30%, using extinction coefficients of 23,000 M^−1^cm^−1^ at 280 nm for the nanobody and 73.000 M^−1^cm^−1^ at 490 nm for the Alexa Fluor 488 dye. To label the Pex5-ybbR protein, reduced coenzyme A (Sigma-Aldrich) was incubated with Alexa Fluor 488--maleimide (Thermo Fisher Scientific) as follows. 2 mM coenzyme A was combined with 3 mM Alexa Fluor 488--maleimide in reaction buffer (50 mM Hepes, pH 7.8, and 100 mM KCl). The sample was incubated at 23°C with gentle agitation for 2.5 h, and the reaction was terminated by addition of 10 mM DTT. Next, 40 µM of labeled coenzyme A was mixed with 15 µM Pex5-ybbR and 6 µM *Bacillus subtilis* 4′-phosphopantetheinyl transferase (SFP synthase) in 50 mM Hepes, pH 7.8, and 10 mM MgCl~2~. The reaction was incubated at 37°C for 1 h, and then the labeled protein was purified on a Superdex 200 10/300 column, using 30 mM Hepes, pH 7.8, and 150 mM KCl as a running buffer. The efficiency of the labeling reaction was determined to be 49%, using extinction coefficients of 98.890 M^−1^cm^−1^ at 280 nm for Pex5-ybbR and 73.000 M^−1^cm^−1^ at 495 nm for the Alexa Fluor 488 dye. Enhancer nanobody against GFP was labeled with Dylight-650 maleimide (Life Technologies) at a 2:1 ratio for several hours. The reaction was quenched with 10 mM β-mercaptoethanol, and excess dye was removed by gel filtration.

Antibodies to Pex5 {#s13}
------------------

Antibodies against purified Pex5 were raised in rabbits by Thermo Fisher Scientific. The terminal bleeds were used for affinity purification of the antibodies. 4 ml of packed Affigel-15 beads (BioRad) was incubated with 24 mg of purified Pex5 in 30 mM Hepes, pH 7.8, and 100 mM KCl overnight at 4°C. The beads were washed and incubated overnight at 4°C with 12 ml of serum in the presence of protease inhibitors. After washing, the antibodies were eluted with 100 mM glycine HCl, pH 2.4, and 150 mM KCl. The eluate was collected in one tenth the volume of 1 M Hepes, pH 7.8. The buffer was exchanged to 30 mM Hepes, pH 7.8, 100 KCl, and 0.25 M sucrose, and aliquots of the sample were frozen in liquid nitrogen.

Antibodies to Pex14 {#s14}
-------------------

Antibodies to Pex14 were raised in rabbits against a GST fusion to Pex14 residues 19 to 78 (GST-cytPex14). Affinity purification was done as described for Pex5 antibodies, using cytPex14 coupled to beads.

Depletion of Pex5 from *Xenopus* extracts by immobilized Pex5 antibodies or Pex14 fragment {#s15}
------------------------------------------------------------------------------------------

The purified Pex5 antibodies (600 µl at 1.5 mg/ml) were coupled to Affigel-15 resin (400 µl) by incubation overnight at 4°C. The beads were washed with buffer and used for depletion of Pex5 from *Xenopus* extracts. The purified Pex14 fragment (6 mg) was incubated with 1 ml of Affigel-15 beads overnight at 4°C. The beads were washed with buffer and used for depletion of Pex5 from *Xenopus* extracts. Cleared extract (300 µl) was incubated with 30 µl of packed beads for 20 min at room temperature on a rotator. To remove the beads, the samples were centrifuged on a Micro-spin column (Pierce) at 300 × g.

Preparation of *Xenopus* cleared egg extracts {#s16}
---------------------------------------------

Interphase crude extracts from *X. laevis* eggs were prepared as described previously ([@bib10]), with the following modifications. All steps were performed at 18°C. Eggs were de-jellied using XB buffer (10 mM Hepes, pH 7.7, 0.1 M KCl, 1 mM MgCl~2~, 0.1 mM CaCl~2~, and 50 mM sucrose) supplemented with 2.4% wt/vol cysteine (Sigma-Aldrich) adjusted to pH 7.8. De-jellied eggs were washed several times with XB buffer and packed in a centrifuge tube (344057; Beckman) by spinning at 300 × g for 1 min, followed by 900 × g for 20 s. Excess buffer was removed, and after addition of protease inhibitors (10 µg/ml leupeptin, 10 µg/ml pepstatin, and 10 µg/ml chymostatin; all from Sigma-Aldrich), the eggs were subjected to a crush spin at 12,100 × g (10,000 rpm in a SW55 Ti Beckman rotor) for 15 min at 16°C. Note that no cytochalasin B, cycloheximide, or energy-regenerating system was added. From here on, the crude extract was kept on ice at all times. The crude extract was carefully collected from tubes by side-puncture using a syringe with an 18-gauge needle and supplemented again with protease inhibitors. The crude extract was placed in centrifuge tubes (347356; Beckman) and spun at 166,000 × g~av~ (50,000 rpm in a TLS-55 Beckman rotor) for 50 min at 4°C. The layer immediately above the light membrane fraction (the cleared extract) was carefully collected from the top of the tube using a wide-bore pipette tip. After mixing, the cleared extract was divided into 50-µl aliquots in PCR tubes, snap-frozen in liquid nitrogen, and stored at −80°C.

Peroxisome import assay using cleared extract from *Xenopus* eggs {#s17}
-----------------------------------------------------------------

Cleared extract aliquots were thawed and maintained on ice at all times. Typical import reactions were prepared in 0.5-ml tubes by pipetting 20 µl cleared extract followed by small molecules or proteins being tested, other than the substrates. When ATPγS was included, the reaction mix was incubated for \<20 min at 23°C before addition of the fluorescent protein. The import reaction was started by addition of SKL-tagged fluorescent protein (or a control fluorescent protein lacking SKL), and the incubation was continued for \>1 h at 18°C before imaging. 8 µl of the reaction mix was mounted between two polyethylene glycol (PEG)--passivated square glass coverslips (22 × 22 mm), sealed with VALAP (vaseline, lanolin, and paraffin mixed at 1:1:1 weight ratio), and imaged on a spinning-disk fluorescence confocal microscope. When the import reaction was followed in real time, a 20-µl reaction volume was mounted as described and maintained on the microscope stage. The incubation temperature was 20--23°C. At least 10 randomly selected microscope fields were captured at each indicated time point. Photobleaching before image acquisition was minimized by using the Perfect Focus System (Nikon), where the microscope objective lens is positioned on a previously unexposed field and the image is acquired without preexposure to excitation light.

Sedimentation of peroxisomes after protein import {#s18}
-------------------------------------------------

A 100-µl import reaction with 0.6 µM mScarlet-SKL was performed for 2 h at 18°C. The sample was centrifuged in a Beckman polypropylene tube (342630) in a TLS-55 swinging bucket rotor at 50,000 rpm for 25 min at 4°C using Teflon tube adapters. The membrane pellet was resuspended in 190 μl of 30 mM Hepes, pH 7.8, 100 mM KCl, 2 mM DTT, protease inhibitors, and 250 mM sucrose using a wide-bore pipette tip. The sample was centrifuged at 30,000 rpm for 25 min at 4°C in a TLS-55 swinging bucket rotor. Resuspension and sedimentation were repeated, and the sample was finally resuspended in 40 µl buffer (final volume ∼60--80 µl).

Flotation of peroxisomes after protein import {#s19}
---------------------------------------------

A 75-µl import reaction with 0.6 µM mScarlet-SKL was performed for 5 h at 18°C and placed in a TLS-55 centrifuge tube (347356; Beckman). A total of 225 µl of 70% sucrose in 30 mM Hepes, pH 7.8, 100 mM KCl, and 2 mM DTT was added in 20-µl increments with mixing in between. The sample was overlaid with 1 ml of 50% sucrose and with 100 µl of 8.5% sucrose and then centrifuged at 4°C in a TLS-55 swinging bucket rotor for 1.5 h at 50,000 rpm. Fractions (200 µl) were taken from the bottom and analyzed by fluorescence imaging and by SDS-PAGE, followed by immunoblotting with affinity-purified Pex14 antibodies.

Fluorescent staining of ER networks in cleared egg extract {#s20}
----------------------------------------------------------

Staining of the ER network was performed as previously described for crude extracts ([@bib42]). 30 µl of extract was incubated with 100 µg/ml DiI-C18 for 45 min at 18°C and diluted 1:10 with fresh extract. After 15 min, the sample was imaged in a fluorescence microscope.

Glass coverslip passivation {#s21}
---------------------------

Square glass coverslips (48366--227; VWR) were placed in metal racks; rinsed sequentially with pure water, ethanol, and pure water; and then air-dried. Coverslips were treated with an oxygen-plasma etcher (500-II Plasma System; Technics) for 4 min at 200-W power. Immediately thereafter, one side of the glass coverslip was layered with a 35 mg/ml solution of 20,000 molecular weight methoxy-polyethylene glycol-silane (JenKem Technology USA), dissolved in 95% ethanol/4.9% water/0.1% glacial acetic acid, and incubated at 80°C for \>5 h. Coverslips were stored in a sealed container at room temperature. Prior to use, they were rinsed with ethanol and pure water, and then air dried.

Fluorescence microscopy {#s22}
-----------------------

All samples were visualized using a spinning-disk confocal head (CSU-X1; Yokogawa) with Borealis modification (Spectral Applied Research) and a quad bandpass 405/491/561/642 dichroic mirror (Semrock). The confocal was mounted on a Ti inverted microscope (Nikon) equipped with a 60× Plan Apo NA 1.4 oil immersion objective or 60× CFI Plan Apochromat NA 1.2 water immersion objective and the Perfect Focus System for continuous maintenance of focus (Nikon). Green fluorescence images were collected using a 491-nm solid-state laser controlled with an acousto-optic tunable filter (AOTF; Spectral Applied Research) and ET525/50 emission filter (Chroma Technology). Red fluorescence images were collected using a 561-nm solid-state laser controlled with an AOTF and ET620/60 emission filter (Chroma Technology). All images were acquired with a cooled charge coupled device camera (ORCA AG; Hamamatsu Photonics) controlled with MetaMorph software (version 7.0; Molecular Devices) and archived using ImageJ (National Institutes of Health). In some cases, linear adjustments were applied to enhance the contrast of images using levels in the image adjustments function of ImageJ.

Quantitative data analysis {#s23}
--------------------------

An automated ImageJ macro script was written to segment and quantify the fluorescence in peroxisomes. The initialization parameters of the automated script were determined for each time course as follows. First, the standard deviation of the background fluorescence was determined in randomly selected regions that did not contain peroxisomes. Second, single foci were randomly selected, and the fluorescence profile on a line across the center of the particle was fit to a Gaussian distribution. This resulted in estimates of particle size and its standard deviation. These parameters were then used in an automated script to segment individual peroxisomes and calculate their mean fluorescence intensity in all images. Specifically, for each raw image, the background was subtracted using a rolling-ball procedure ([@bib36]) with a ball diameter twice the preestimated particle size. Then, the image was subjected to a Laplacian filter to enhance the contrast of the particles regardless of their fluorescence intensity. The filter used as a parameter the previously calculated particle size standard deviation. The resulting images were then inverted, as they originally show the particles as dark objects on a bright background. The images were then segmented using a standard automated segmentation routine based on statistical region-merging (Robust Automatic Threshold Selection ImageJ plugin; [@bib45]). During this analysis, the pre-estimated standard deviation of background pixel values was used as a parameter. The resulting image was converted to a binary image, where the positive values indicate the position, size, and shape of the peroxisomes. These images were then used in the standard ImageJ "analyze-particles" function to generate a list of regions of interest (ROIs). The ROIs were then transferred to the background-subtracted initial unprocessed image and used to determine the mean fluorescence per peroxisome. For each time point, \>10 images were analyzed, giving 15,000--20,000 particles. The number of ROIs gives the number of peroxisomes.

Online supplemental material {#s24}
----------------------------

Fig. S1 shows the preparation and characteristics of cleared *Xenopus* egg extract. Fig. S2 shows purified proteins analyzed by SDS-PAGE. Fig. S3 shows that ATP depletion blocks peroxisome protein import. Fig. S4 compares the affinity of WT and mutant Pex5 for import substrate. Fig. S5 shows that GFP can be piggyback imported by nanobody-SKL. Video 1 shows the mobility of puncta labeled with mScarlet-SKL followed in real time.
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###### Video 1
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